ArticleBiomedical microdevices2026
Thermoplastic elastomer based microfluidic gradient generator for cell culture and drug testing.
Article in Biomedical microdevices, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microfluidic systems are increasingly utilized in preclinical research, however, developing platforms that are compatible with large-scale manufacturing remains a critical challenge. In this regard, we show that thermoplastic elastomer (TPE)-based microfluidic chips could be a viable alternative to traditional poly(dimethylsiloxane) (PDMS) devices for drug testing applications. Microfluidic concentration gradient generators are essential components in these systems, enabling local spatial and temporal control of biochemical stimuli for applications such as cellular response studies and drug screening. TPEs offer key advantages, especially, optical transparency, flexibility, and compatibility with high-throughput fabrication processes compared to PDMS, thereby enhancing commercialization potential. This study demonstrates the design and fabrication of TPE-based microfluidic devices incorporating concentration gradient generators that allow precise control over solute distributions. Gradient formation was validated through numerical modeling and co-flow experiments using fluorescent dyes. The platform supported the co-culture of human lung fibroblast cells and human colon adenocarcinoma cells (HT-29), which exhibited coordinated responses to gradients of fetal bovine serum (FBS) and sepantronimum bromide (YM-155). Performance benchmarks against PDMS chips demonstrated comparable functionality, underscoring the potential of TPE-based devices for future scalable and cost-effective drug testing and cellular assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.